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RESUmEn
Objetivo: Evaluar la seguridad de la ejecución 
de las técnicas tradicional y protegida de la 
recolección de aspirado traqueal e identificar 
la concordancia cualitativa y cuantitativa de 
los resultados de los cultivos microbiológi-
cos entre estas técnicas. Método: Investiga-
ción clínica, prospectiva, comparativa, ciega 
simple. La muestra fue constituida por 54 
pacientes mayores de 18 años que fueron 
sometidos a ventilación mecánica invasiva 
durante 48 horas o más y con sospecha de 
Neumonía Asociada a la Ventilación Mecáni-
ca. Las dos técnicas fueron implementadas 
en el mismo paciente, una inmediatamente 
posterior a la otra. El orden de ejecución de 
las técnicas fue aleatorio, hecho por un soft-
ware especializado. Resultados: No hubo 
eventos significativos en la disminución de la 
saturación de oxígeno, inestabilidad hemodi-
námica y hemorragias traqueo bronquiales 
(p<0,05) y aunque ocurrieron diferencias en 
algunas cepas, hubo concordancia cualitativa 
y cuantitativa entre las técnicas (p<0,001). 
Conclusión: El uso de la técnica protegida no 
ofrece ninguna ventaja sobre la técnica tra-
dicional y la aplicación de ambas técnicas es 
segura para el paciente.
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RESUmo
Objetivo: Avaliar a segurança da execução 
das técnicas tradicional e protegida de co-
lheita de aspirado traqueal e identificar a 
concordância qualitativa e quantitativa dos 
resultados de culturas microbiológicas en-
tre as técnicas. Método: Pesquisa clínica, 
prospectiva, comparativa, simples-cega. 
A amostra foi constituída de 54 pacientes 
com idade ≥18 anos, submetidos à ventila-
ção mecânica invasiva por período ≥48 ho-
ras e com suspeita de Pneumonia Associa-
da à Ventilação Mecânica. As duas técnicas 
foram implementadas no mesmo paciente, 
uma imediatamente seguida da outra, sen-
do a ordem de execução aleatória, segundo 
randomização por software especializado. 
Resultados: Não ocorreram eventos signifi-
cativos de queda da saturação de oxigênio, 
instabilidade hemodinâmica e hemorragias 
traqueobrônquicas (p<0,05) e, embora te-
nham ocorrido divergências em algumas 
cepas, houve concordância qualitativa e 
quantitativa entre as técnicas (p<0,001). 
Conclusão: A utilização da técnica prote-
gida não proporciona vantagem em detri-
mento da tradicional e a execução de am-
bas as técnicas foi segura para o paciente.
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AbStRACt
Objective: To evaluate the safety of the per-
formance of the traditional and protected 
collection techniques of tracheal aspirate 
and to identify qualitative and quantitative 
agreement of the results of microbiological 
cultures between the techniques. Method: 
Clinical, prospective, comparative, single-
blind research. The sample was composed 
of 54 patients of >18 years of age, under-
going invasive mechanical ventilation for 
a period of ≥48 hours and with suspected 
Ventilator Associated Pneumonia. The 
two techniques were implemented in the 
same patient, one immediately after the 
other, with an order of random execution, 
according to randomization by specialized 
software. Results: No significant events oc-
curred oxygen desaturation, hemodynamic 
instability or tracheobronchial hemorrhage 
(p<0.05) and, although there were differ-
ences in some strains, there was qualita-
tive and quantitative agreement between 
the techniques (p<0.001). Conclusion: Uti-
lization of the protected technique provid-
ed no advantage over the traditional and 
execution of both techniques was safe 
for the patient.
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intRodUCtion
Currently, the accurate diagnosis of ventilator-associ-
ated pneumonia (VAP) causes great difficulty and remains 
a constant challenge for clinical practice. The adequate 
management of patients with this type of infection is mul-
tifactorial, as it depends on a series of knowledge, practic-
es and human, material and organizational resources. Ear-
ly initiation of necessary, effective and safe antimicrobials 
is an integral part of this context and is integrated, in part, 
to the diagnostic procedures employed in institutions.
The tracheal aspirate (TA), whose collection is one of the 
attributions of the nurse caring for intubated patients, is a 
method of obtaining tracheal secretions for culture and mi-
crobiological diagnosis of VAP. It is easily performed at the 
bedside, relatively simple, minimally invasive and inexpen-
sive, has a proven acceptable accuracy and requires minimal 
investment for the training of health professionals(1).
Some authors(2-3) point out, however, that further evi-
dence is required for the management of TA, especially 
with regard to the techniques of microbiological collection 
and processing of the samples, because there are different 
protocols and some unresolved issues. Bacterial and fun-
gal colonization of the internal surface of the endotracheal 
tube (ETT) in the form of biofilm is one of the factors which 
contributes most to harvesting of non-representative 
samples, the occurrence of false results or questionable 
cultures with no diagnostic value, given the possibility of 
contamination of the sample during the collection phase.
It is believed that the biofilm, in addition to causing seri-
ous recurrent infections, acts as a reservoir for microorgan-
isms that affects the microbiological analysis of tracheo-
bronchial content and causes doubts in interpreting the 
results of cultures due to contamination, colonization and 
infection(4). Therefore, microorganisms that colonize the ETT 
and are not causing pneumonia, may be collected by TA by 
traditional technique and impair the diagnostic accuracy(5).
Accordingly, since the infection occurs in the pulmo-
nary parenchyma and not in the ETT, it was inferred that 
the procurement of tracheobronchial secretions free from 
agents of the biofilm of the ETT, through the protected 
technique, would provide better results than culture for 
the diagnosis of VAP. Thus, the following inquiry arose: 
does the collection of TA by the protected technique, that 
is, without the aspiration probe itself entering in contact 
with the inner surface of the ETT, present a correlation 
with the traditional technique and is it safe for the pa-
tient? With the scope to investigate this doubt that ema-
nated from clinical practice, and to provide advancements 
to confirm or refute TA using the protected technique, this 
investigation was proposed, which had as its objectives to 
evaluate the safety of the performance of traditional and 
protected collection techniques for TA and to identify the 
qualitative and quantitative agreement of the results of 
microbiological cultures between the techniques.
mEtHod
This was a clinical, prospective, comparative, single-
blind study. Data collection was conducted from January 
to September of 2013, in a general ICU with adult pa-
tients in a university hospital in the state of Mato Grosso 
do Sul, Brazil. Purposive sampling was conducted, with 
inclusion of patients from the age of 18, undergoing in-
vasive mechanical ventilation (MV) for a period of more 
than 48 hours and with suspected VAP; and the exclusion 
of those with pneumonia prior to the MV. The suspected 
pneumonia was determined by the treating physician and 
was based on the presence of at least two of the follow-
ing criteria: leukocytosis (>11,000 cells/mm3) or leukope-
nia (<4,000 cells/mm3), fever (>38.4°C) or hypothermia 
(<36.5°C), new or progressive infiltrate on chest radio-
graph and purulent tracheobronchial secretions(6). The 
VAP was microbiologically defined, when the TA collected 
by the traditional technique reached a count ≥105 colony 
forming units per millilitre (UFC/ml)(1).
The study sample was composed of 54 patients who 
generated 80 pairs of microbiological samples – a mean 
of 1.5 collected per patient. Nine patients presented with 
suspected VAP more than one time during their stay in 
the ICU, therefore, their data were collected more than 
one time. The protected and traditional techniques were 
adopted for the same patient, one immediately after the 
other, conducted by a nurse, who was aided by a physio-
therapist, both specialists in intensive care, experienced 
and trained for execution of the procedures.
The order of execution of the techniques in each 
patient were randomized, according to randomization 
software (http://www.randomization.com). Before the 
collection, the inspiratory fraction of oxygen (FiO
2
) was 
increased to 100% for one minute and, during the proce-
dures, arterial pressure, cardiac frequency, oxygen satura-
tion via pulse oximetry and hemorrhages were monitored. 
In both techniques, an open suction system was used. It is 
emphasized that, a week before the sample collection, a 
pilot study was conducted with five patients for calibra-
tion of the procedures.
The collection of TA by the traditional technique was 
performed according to standard procedure, that is, us-
ing a 12 French (Fr) siliconized polyvinyl chloride (PVC) 
tracheal aspiration probe (Embramed®, Brazil). This was 
introduced through the ETT until resistance was encoun-
tered (level of the carina in the trachea), and retracted ap-
proximately 2cm. This was followed by the release of the 
vacuum and the probe was delicately removed using turn-
ing movements, from which the secretion was aspirated 
into a sterile polypropylene collector tube (bronco collec-
tor; Zammi®, Brazil).
For the protected technique, a tracheal probe (#10 Fr) 
and another nasogastric tube (#20 Fr) were used, the lat-
ter being cut to a length 7cm longer than that of the ETT. 
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Subsequently, it was introduced into the ETT until it was 2 
cm beyond the distal end of the tube, thereby being exter-
nalized 5cm relative to the proximal end. Afterwards, the 
tracheal probe itself was introduced into the nasogastric 
tube, and secretions were aspirated (Figure 1). No saline 
solution was used for either sample to liquefy secretions, 
and strictly aseptic principles were followed.
Following the microbiological collection, the samples 
were transported to the microbiology laboratory, in a time 
not exceeding 30 minutes, and were subjected to identical 
microbiological and blinded processing, that is to say, with-
out the lab staff knowing by which technique the samples 
were collected. Only samples with less than 25 epithelial 
cells per field (100x magnification) were considered, and 
they were processed as suggested by the protocol Cumi-
tech 7B of the American Society for Microbiology(7).
The tracheal secretion (the most purulent portion), 
therefore, was liquefied with the addition of an equal vol-
ume of 1% N-acetyl cysteine and subsequent homogeni-
zation (Vortex Mod QL-901-BIOMIXE®) for one minute at 
3,000 rpm. Subsequently, a 0.1 ml sample was diluted in 
9.9 ml sterile physiological solution; 0.01 ml was seeded 
(calibrated loop) in Petri dishes containing MacConkey 
agar, blood agar azide and chocolate agar. Incubation of 
the dishes was performed in aerobiosis at 35 ± 1ºC for 24 
to 48h, except for the chocolate agar, in capnofilia (5% of 
CO
2
) at 35 ± 1ºC for 24 to 48h. The first quantitative read-
ing was performed after 24 hours and, in cases of difficult 
macroscopic differentiation or absence of colonies, re-in-
cubated for another 24h(7).
In the interpretation of results, each colony corre-
sponded to 20,000 CFU/ml, and it was considered to be 
TA positive when the count was ≥105 CFU/ml(1). The iden-
tification of the microorganism was performed by means 
of the automation device, Vitek® 2 AES (BioMérieux, 
France). The ethical precepts of Resolution No. 466/12 
of the National Health Council were respected, and the 
institutional Committee on Ethics in Research (CER) with 
human beings approved the project, under protocol 
number 114311/2012.
Data were stored in the Microsoft Excel software, 2010 
version, and statistically analyzed using Minitab for Win-
dows (version 14). In addition to descriptive statistics, the 
chi-square (χ²) and Fisher exact tests, both with 95% reli-
ability (significant p value <0.05), were used, and applied 
at the crossing of categorical variables.
RESULtS
The analysis involved 54 patients with suspected VAP 
who generated 160 samples for cultures (80 pairs, each 
with collection using the protected and traditional tech-
nique). The demographic and clinical characteristics of 
these patients are presented in Table 1.
Figure 1 – Arrangement of the devices used in the collection 
of the TA by the protected technique: (a) Collection bottle; (b) 
Output for vacuum; (c) Entry of secretions; (d) Aspiration probe 
#10 Fr; (e) thick probe #20 Fr; (f) Orotracheal tube.
Continued…
Table 1- Demographic and clinical characteristics of the patients 
- Campo Grande, MS, Brazil, 2013
Variables Resultsn° or mean (%) ± SD
Subjects (n) 54
Age (years) 63.8 ± 17.5
Sex
Masculine 31 (57.4)
Feminine 23 (42.6)
Days spent in hospital (days) 19 ± 9.8
Days of hospitalization in ICU (days) 11 ± 9.2
Origin
Emergency Room 34 (63)
Clinical Medicine 11 (20.4)
Clinical Surgery 6 (11.1)
Other 3 (5.5)
Time on MV (hours) 314 ± 208.6
Comorbidities
SAH 34 (63)
DM 19 (35.2)
Infectious-Parasitic Diseases 15 (27.8)
CHF 14 (25.9)
Neurological injuries 11 (20.4)
Digestive injuries 11 (20.4)
COPD 8 (14.8)
CRI 6 (11.1)
Câncers 3 (5.6)
APACHE II on admission 24,8 ± 5.4
Use of antimicrobials 54 (100)
Pharmacological class
Antibacterials 52 (96.3)
Carbapenemics 38 (70.4)
Penicillins 31 (57.4)
Glycopeptides 29 (53.7)
Macrolides 26 (48.1)
Polymyxins 24 (44.4)
Aminoglycosides 15 (27.8)
Fluoroquinolones 11 (20.4)
Cephalosporins 10 (18.5)
Antifungals 24 (44.5)
Triazoles 18 (33.3)
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Globally, the majority of the patients were male; of 
advanced age; with many days of hospitalization and MV; 
originating from the emergency room; affected by different 
comorbidities; and with a high estimated mortality score by 
the APACHE II, which led to the outcome of deaths in the 
majority of the subjects; increased number of leukocytes 
and rods; normothermic; and all were on antibiotic therapy.
Considering the microorganism and CFU/ml, when 
the techniques were implemented in the same patient, 
one immediately after the other, the correlation between 
these was statistically significant (Table 2).
Table 2 – Agreement between the analyzed techniques, accord-
ing to microorganism isolated and UFC/ml - Campo Grande, MS, 
Brazil, 2013
Microrganism x 
CFC/ml
Agreement 
CFU/ml Odds Ratio P*
Yes No Estimate Lower Upper
Agreement
Microrganism
Yes 58 6
54.13 11.54 253.98 <0,001
No 3 13
*Fisher exact test
When the results of culture isolates were revealed as 
identical or absent in both the techniques, this was inter-
preted as concordance of the microorganism - regardless 
of the count; and agreement of the CFU/ml when there 
was an identical count <105 or ≥105 for both techniques. 
Table 2 presents the agreement resulting from the cross-
ing of these variables. It was perceived that, of the 80 
pairs of samples, 58 presented the same microorganism 
and CFU/ml simultaneously. Therefore, the overall agree-
ment between the protected and traditional technique 
was 72.5% (p <0.001).
… Continuation
Continue…
Variables Resultsn° or mean (%) ± SD
Echinocandins 11 (20.4)
Polyenes 5 (9.3)
Time on antibiotic therapy (days) 16.2 ± 13.1
White blood count
Leukocytes (cell/mm3) 19.654 ± 17.268
Neutrophils (%) 79.3 ± 15.3
Rods (%) 18.5 ± 11.6
Lymphocytes (%) 8.2 ± 5.1
Temperature (°C) 37.4 ± 0.6
Aspect of the tracheal secretions
Mucoid 43 (79.6)
Purulent 11 (20.4)
Discharge from the ICU
Death 30 (55.6)
Discharge 21 (38.9)
Transfer 3 (5.5)
note: sah: systemic arterial hypertension; dm: diabetes mellitus; 
ChF: Congestive heart Failure; Copd: Chronic obstructive 
pulmonary disease; Cri: Chronic renal insufficiency; apaChe ii: acute 
physiology and Chronic health evaluation.
Table 3 – Comparison of the tracheal aspirate cultures collected using protected and traditional technique. Campo Grande, MS, Brazil, 2013
Result
nº. (%)
episodes
Microrganism(s) recovered
Protected technique Traditional technique
1 44 (55) Identical Identical
2 20 (25) None None
3 2(2.5) None Candida albicans
4 1 (1.25) None Klebsiella pneumoniae
5 1(1.25) Acinetobacter baumanii None
6 1 (1.25) Pseudomonas aeruginosa None
7 1 (1.25)
Pseudomonas aeruginosa
Candida albicans
Pseudomonas aeruginosa
–
8 1 (1.25)
Candida albicans
Staphyloccus epidermidis
Pseudomonasaeruginosa
Candida albicans
Staphyloccus epidermidis
–
9 1 (1.25)
Candida tropicalis
Pseudomonas aeruginosa
Candida tropicalis
–
10 1 (1.25)
Acinetobacter baumanii
Staphyloccus epidermidis
Acinetobacter baumanii
–
11 1 (1.25)
Candida albicans
Klebsiella pneumoniae
Enterococcus faecium
Candida albicans
–
–
12 1 (1.25)
Staphylococcus aureus
Stenotrophomonas maltophilia
Staphylococcus aureus
–
13 1 (1.25)
Pseudomonas aeruginosa
Klebsiella pneumoniae
Stenotrophomonas maltophilia
Staphylococcus cohnii
–
Pseudomonas aeruginosa
–
–
–
Staphylococcus warneri
14 1 (1.25)
Staphylococcus aureus
–
Staphylococcus aureus
Klebsiella pneumoniae
15 1 (1.25)
Pseudomonas aeruginosa
–
Pseudomonas aeruginosa
Klebsiella pneumoniae
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According to Table 3, considering only the isolated 
microorganism, regardless of a count lower or higher 
than 105 CFU/ml, it was verified that there was com-
plete concordance between both techniques in 80% 
of the episodes of suspected VAP (results 1 and 2). In 
five episodes (6.25%), there were completely discor-
dant results - negative microbial culture for one of the 
techniques and positive for the other. In three episodes 
(results 3 and 4) there was no retrieval of agents when 
the protected technique was performed; while for the 
traditional technique, in two episodes (results 5 and 6) 
the same situation occurred. In all other cases, the re-
sults were quite varied, with isolation of extra micro-
organisms occurring (additional strains found in one 
technique, but not the other), both in the protected 
technique (outcomes 7, 8, 9, 10, 11, 12 and 13) as well 
as the traditional (results 13, 14, 15, 16 and 17). It is 
noteworthy that 70% (7/10) of the identified extra mi-
croorganisms in the protected technique had a count 
less than 105 CFU/ ml, as compared to 42.9% (3/7) of the 
traditional technique (p <0.05).
In relationship to the safety of the two techniques, 
there were no statistically significant adverse events 
(p<0.05) such as oxygen desaturation, hemodynamic in-
stability or tracheobronchial hemorrhage.
diSCUSSion
In the search for improvements in the quality of col-
lected samples of tracheal secretions, that is to say, those 
free from contamination, this study examined the correla-
tion between two collection techniques of TA for micro-
biological diagnosis of VAP. The results suggest that there 
were no statistically significant differences (p <0.001) be-
tween the techniques, both qualitatively (isolated micro-
organism) and quantitatively (CFU/ml).
Various extras microorganisms were isolated in both 
techniques. In this case, although the cultures derived 
from samples collected by the protected technique pre-
sented a higher percentage of extra agents, such as the 
count <105 CFU/ml (70% vs. 42.9%), it is not prudent to 
assert that one technique was more accurate compared 
to the other for the diagnosis of VAP, because there is no 
concept that distinguishes contamination from coloniza-
tion in tracheal secretions. It was therefore not possible to 
distinguish whether these extra agents were microorgan-
isms of the biofilm of the ETT or colonized from the lung 
parenchyma(6). One of the possible alternatives would be 
to analyze genetically, by polymerase chain reaction or a 
compatible method, the extra microorganisms isolated in 
the protected and traditional technique with those pres-
ent in the ETT biofilm.
Taking into consideration only the extra isolates with 
a count <105 CFU/ml, and using a classification proposed 
by an extensive literature review(8), in the protected 
technique four (57.1%) agents were common causes of 
VAP (P. aeruginosa, 2 K. and E. faecium), one (14.3%) 
rarely provoked a referred infection (S. maltophilia) and 
two (28.6%) were not important epidemiological causes 
(S. cohnii and S. epidermidis). Whereas in the traditional 
technique, two (66.7%) were common causes of VAP 
(P. aeruginosa and A. baumannii) and one (33.3%) was 
not causative (S. hominis). This further complicates the 
definition of which technique is more reliable, because, 
of course, some of these agents may be contaminants, 
however, they may also be colonizers with the potential 
to develop and cause infections.
To demonstrate this, using surveillance cultures of TA, 
a prospective cohort(9), that included 200 patients, had as 
one of its objectives to identify the colonizers of pulmo-
nary parenchyma and their respective ability to evolve 
and, later, to cause VAP. According to the results, the ma-
jority (60.9%; 14/23) of the causative microorganisms of 
VAP were initially present as colonizers of the pulmonary 
parenchyma. The rates of colonization following the lat-
er development of VAP were relative higher for nonfer-
menting bacterias (46.4%), methicillin-resistant S. aureus 
(33.3%) and Enterobacteriaceae(22.2%).
In any case, these results contradict the expectation 
that the protected technique recovers a lower quantity of 
extra microorganisms, since it avoids the contact of the 
aspiration tube itself with the microorganisms present in 
the biofilm of the ETT, and thereby prevents what is col-
lected, cultivated and falsely released as pathogens of the 
pulmonary tissue.
The primary reason that may have contributed to 
this finding is that these extra microorganisms may have 
colonized pulmonary tissue, since the genetic correla-
tion with those of the ETT biofilm was not studied. The 
second is related to the fact that the intubated patient is 
subjected to various daily endotracheal aspirations. This 
… Continuation
Result
nº. (%)
episodes
Microrganism(s) recovered
Protected technique Traditional technique
16 1 (1.25)
Pseudomonas aeruginosa
Acinetobacter baumanii
–
Pseudomonas aeruginosa
Acinetobacter baumanii
Staphylococcus hominis
17 1 (1.25)
Candida parapsilosis
–
–
–
Candida parapsilosis
Pseudomonas aeruginosa
Acinetobacter baumanii
Elizabethkingia meningoseptica
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can result in dissemination of biofilm agents towards 
the lower airways, and vice versa. From this perspective, 
the TA collected by the protected and traditional tech-
nique would not differ as to the presence or absence of 
organisms from ETT. The third is that the thicker probe 
may have caused friction to the internal wall of the ETT 
and dislocated biofilm microorganisms to the lower air-
ways, as well as to its own distal or inner surface and, 
subsequently, all of this material was collected by the 
aspiration probe.
Whether these are the real reasons that led to the 
results encountered or not, the fact is that the protected 
technique showed statistically significant agreement in 
relation to the traditional and, safeguarding the limita-
tions of the study, showed no significant benefits. Given 
this result, we do not recommend the use of the tech-
nique, considering this is potentially capable of increas-
ing hospital costs, since it demands a longer collection 
time, requires specific materials in relationship to the 
traditional and that, if agents actually include the bio-
film of the ETT in the samples, it can lead to errors of 
interpretation or false positive results or undue changes 
in antibiotic therapy.
It is noteworthy that, after three days of intubation 
and MV, the lumen of the ETT became heavily colonized 
by various microorganisms. These move on to survive 
on the abiotic surface of the tube in the form of ma-
ture biofilm, that is, in a structured system of commu-
nities, coordinated and functional with a high degree 
of organization(10). Studies have shown that the occur-
rence of VAP and other infection in the lower respira-
tory tract can be a consequence of the recurring trans-
ference of agents present in this biofilm to the lower 
airways(5,10-12). A recent randomized clinical controlled 
trial(10) found that more than 60% of patients had iso-
lates of the same species in both the biofilm of the ETT 
as well as in the bronchial secretion, and the tip of the 
ETT was the region with the highest density of patho-
gens associated with VAP.
As yet there is no gold standard for the microbiologi-
cal diagnosis of VAP(13) and the problems related to the 
excessive use of antibiotics and antimicrobial resistance 
continue to grow; improving the accuracy of microbio-
logical diagnosis of VAP becomes an essential element for 
ensuring adequate antibiotic coverage for Multi-Drug Re-
sistant Organism (MDRO), and to limit the use and dura-
tion of empirically prescribed broad spectrum antibiotic 
therapy. In the context of the use of quantitative culture 
techniques, collecting tracheal secretions stands out as 
crucial step for a precise and accurate diagnosis(14). On the 
other hand, the biofilm of the ETT is a variable that can 
adversely impact this process.
It is widely recommended that the collection of any 
type of biological material for culture should occur in 
the absence of antibiotic therapy, since the previous 
use of antibiotics can cause false negative results. In 
the case of cultures of tracheobronchial secretions, this 
has been a problem for both clinical practice as well as 
research because, depending on the profile of the ICU 
patients, the vast majority of those with suspected VAP 
are seriously ill and have also been subjected to vari-
ous procedures and treatments, many of which have 
the potential to propitiate or develop clinical changes 
typical of infection. Sometimes, many patients receive 
antibiotics before the suspicion of VAP; some, before 
arriving in intensive care(14).
In this study, 100% of the patients were using an-
timicrobials – many of broad spectrum (Table 1). This 
could be a limitation, therefore, especially considering 
the increase in the rates of nosocomial infections, the 
emergence of MDRO strains, pressure suffered by the 
physician for the early initiation of antibiotic therapy, 
the state in which the patient is found when there is 
the suspicion of VAP, and antibiotic use in ICU for non-
pneumonic causes. It is believed that the results of this 
study are valid, they correspond to the current national 
and international health scenario, and it is not advan-
tageous to conduct studies in a reality that is different 
from the current one.
Although recommended in some documents(7,15), it is 
noteworthy that 0.9% saline was not instilled to facilitate 
the collection of secretions, because it would compromise 
the comparison between techniques. Furthermore, if 
the results are expressed in CFU/ml, the aforementioned 
practice turns into an unstable mathematical relationship, 
since the amount of fluid instilled and later retrieved is 
variable. For example, if only a small volume of liquid is 
recovered by aspiration, then, the bacteria count may be 
mistakenly larger due to the smaller volume of diluent. 
On the other hand, if a larger volume of liquid is recov-
ered, the concentration will be lower at the expense of 
increased dilution(2).
Although the implementation of the protected tech-
nique occluded more than 50% of the lumen of the ETT, 
it is important to stress that no iatrogenic complications 
of an oxy-hemodynamic order were observed between 
the relevant techniques, even hemorrhage. It was inferred 
that the latter would be one of the possible complications 
related to the protected technique, since the outer tube 
was not blunted and was relatively thicker and more rigid 
than traditional aspiration probes. Only one patient had 
bleeding during collection, but this was unrelated to the 
protected technique because the hemorrhaging started 
during the execution of the traditional technique (the first 
to be performed on the patient, according to randomiza-
tion). Furthermore, the patient showed severe changes in 
blood clotting and invariably bled during routine endotra-
cheal aspiration procedures.
This study had several limitations, including the non-
probabalistic sample, not including other diagnostic 
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methods for VAP – such as bronchoalveolar lavage – in 
order to compare the results of cultures between the 
TA techniques and not to analyze by means of tests the 
genotyping assays of agreement between the recovered 
microorganisms in both the techniques possible with the 
biofilm of the ETT.
However, despite these limitations, this is the first 
study to our knowledge that focused on comparative 
analysis of the tracheal aspirate using the traditional ver-
sus protected method. The findings of this study raise 
an important issue, potentially able to interfere with the 
quality of the results of the tracheal aspirate culture to 
support the diagnosis of VAP, suggesting the need for fur-
ther discussions and reflections through robust and well-
designed research.
ConCLUSion
We conclude that the tested techniques are statistical-
ly equivalent, as to the quantity and quality of recovered 
microorganisms. They are safe for the patient, because 
relevant iatrogenic complications of an oxy-hemodynamic 
and hemorrhagic order were not found. Extra microorgan-
isms were found in both techniques. These are potentially 
capable of interfering in the quality of the results of mi-
crobiological culture and leading to adverse effects in the 
management of antibiotics, with the potential for inad-
equate or excessive treatment. However, it was not pos-
sible to distinguish whether these results represent micro-
organisms present in the biofilm of the ETT, in the lower 
respiratory tract, or in both.
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